Deborah A. Kuban, M.D., F.A.C.R., F.A.S.T.R.O.
Department of GU Radiation Oncology, Division of Radiation Oncology
About Dr. Kuban
I have been involved with clinical radiation and radiation-related research for the past 25 years. For the last 10 years, my efforts have been directed solely at Genitourinary cancers. As evidenced by my biosketch, I have collaborated on several grants and studies involving long-term follow-up and treatment related effects. I have done research on cancer outcomes, treatment associated complications and quality of life issues. I was one of the developers of our institutional Genitourinary Survivorship Clinic.
Present Title & Affiliation
Primary Appointment
Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1981 | Medical College of Georgia, Augusta, GA, USA, MD, Medicine |
| 1977 | Valdosta State College, Valdosta, GA, USA, BS, Biology |
Postgraduate Training
| 1982-1985 | Residency, Radiation Oncology, Eastern Virginia Graduate School of Medicine, Norfolk, VA |
| 1981-1982 | Internship, General Surgery, Eastern Virginia Graduate School of Medicine, Norfolk, VA |
Board Certifications
| 1986 | Therapeutic Radiology, American Board of Radiology |
| 1981 | Diplomat, National Board of Medical Examiners |
Experience & Service
Administrative Appointments/Responsibilities
Site Lead, Scripps - MD Anderson Cancer Network Partner, Houston, TX, 2017 - 2022
Deputy Division Head, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2019
Executive Director, Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019
Medical Director, Genitourinary Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2016
Medical Director, Department of M. D. Anderson Physicians Network, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2019
Medical Director, Department of Patient Affairs, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2019
Faculty Host Advocate, The University of Texas MD Anderson Cancer Center Physicians Network, Houston, TX, 2006 - 2016
Medical Director, Multi-disciplinary Prostate Cancer Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2019
Genitourinary Section Chief, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2015
Institutional Committee Activities
Member, MD Anderson Cancer Network Steering Committee, 2014 - 2018
Member, International Advisory Committee, MD Anderson Cancer Network, 2014 - 2022
Member, Houston Strategy Workgroup, 2014 - 2015
Member, Global Academic Programs Steering Committee, 2012 - 2014
Member, Physician Relations Faculty Advisory Board, 2012 - 2020
Member, National Clinical Expansion Steering Committee, 2012 - 2014
Member, Regional Cancer Center Strategic Committee, 2011 - 2012
Member, Committee on Faculty Awards, 2011 - 2012
Member, Banner MD Anderson Steering Committee, 2011 - Present
Member, MD Anderson Physicians Network Annual Symposium Planning Committee, 2010 - 2014
Member, Genitourinary Center Survivorship Committee, 2008 - 2019
Member, Clinical Effectiveness Subcommittee of the Medical Practice Committee, Working Group on Prostate, Bladder and Testicular Cancer, 2008 - Present
Member, Radiation Oncology Divisional Recruitment Committee, 2007 - 2017
Member, Radiation Oncology Promotion and Tenure Committee, 2007 - 2017
Member, Physicians Network Credentials Committee, 2006 - 2022
Member, Division Leadership Committee, Radiation Oncology Department, 2003 - 2015
Member, Genitourinary Center Steering Committee, 2001 - 2010
Honors & Awards
| 2017 | International Health Professional of the year, International Biographical Center of Cambridge, England |
| 2015 | Top Doctor in Houston Texas, International Association of Radiologists, In Leading Physicians of the World |
| 2015 | President's Recognition for Faculty Excellence Award, The University of Texas M. D. Anderson Cancer Center |
| 2014 | America's Top Doctors, Castle Connolly Guide |
| 2013 | Golden Finger Award, Best Presentation, Sun, Sand & Seeds Conference Boca Raton, FL |
| 2008 | International Who's Who of Professional & Business Women, The American Biographical Institute |
| 2008 | Best Doctors in America: Texas |
| 2007 | Leading Health Professionals of the World, Cambridge, England |
| 2007 | Fellow, American Society for Therapeutic Radiology and Oncology |
| 2006 | Fellow, American College of Radiology |
| 2003 | The Global Directory of Who's Who, New York, NY |
| 2003 | Faculty of 1000 in Medicine, Philadelphia, PA |
| 2002 | Houston's Best Doctors, Inside Houston Magazine |
| 2002 | Houston's Best Women Doctors, Inside Houston Magazine |
| 1999 | Pfizer Scholar in Urology Award |
| 1997 | 2000 Best Doctors in the United States, M.M. Braun Publishers |
| 1996 | The Best Doctors in America: Southwest Region, Radiation Oncology, Genitourinary, Woodward/White Publishers |
| 1994 | The Best Doctors in America, Radiation Oncology, Genitourinary, Woodward/White Publishers |
| 1992 | Listed among the Best Cancer Specialists in the U.S., Radiation Oncology, Genitourinary, Good Housekeeping Magazine |
| 1991 | Presentation in Plenary Session, 33rd Annual Meeting, American Society for Therapeutic Radiology and Oncology |
| 1989 | Travel Grant, American Society for Therapeutic Radiology and Oncology |
| 1989 | Travel Grant to the European Society for Therapeutic Radiology and Oncology Meeting, European Society for Therapeutic Radiology and Oncology |
| 1988 | Lee's Friends Volunteer Service Award |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):2943-2949, 2018. e-Pub 2018. PMID: 30106637.
- Carvalho ÍT, Baccaglini W, Claros OR, Chen FK, Kayano PP, Lemos GC, Weltman E, Kuban DA, Carneiro A. Genitourinary and gastrointestinal toxicity among patients with localized prostate cancer treated with conventional versus moderately hypofractionated radiation therapy: systematic review and meta-analysis. Acta Oncol 57(8):1003-1010, 2018. e-Pub 2018. PMID: 29882448.
- Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial. Am J Clin Oncol 41(6):558-567, 2018. e-Pub 2016. PMID: 27635624.
- Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int 121(4):540-548, 2018. e-Pub 2017. PMID: 28941030.
- Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2017. PMID: 29229325.
- Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int 121(1):69-76, 2018. e-Pub 2017. PMID: 28710901.
- Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer Prostatic Dis 20(4):389-394, 2017. e-Pub 2017. PMID: 28462945.
- McQuade JL, Prinsloo S, Chang DZ, Spelman A, Wei Q, Basen-Engquist K, Harrison C, Zhang Z, Kuban D, Lee A, Cohen L. Qigong/tai chi for sleep and fatigue in prostate cancer patients undergoing radiotherapy: a randomized controlled trial. Psychooncology 26(11):1936-1943, 2017. e-Pub 2016. PMID: 27548839.
- Yennurajalingam S, Tannir NM, Williams JL, Lu Z, Hess KR, Frisbee-Hume S, House HL, Lim ZD, Lim KH, Lopez G, Reddy A, Azhar A, Wong A, Patel SM, Kuban DA, Kaseb AO, Cohen L, Bruera E. A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer. J Natl Compr Canc Netw 15(9):1111-1120, 2017. PMID: 28874596.
- Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium, Michalski JM. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. Int J Radiat Oncol Biol Phys 98(2):304-317, 2017. e-Pub 2017. PMID: 28463150.
- Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. Am J Mens Health 11(1):73-81, 2017. e-Pub 2016. PMID: 25891393.
- Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, Kuban DA, Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, Garin O, Ferrer M, Hamstra DA, Spratt DE. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. Int J Radiat Oncol Biol Phys 96(4):770-777, 2016. e-Pub 2016. PMID: 27663760.
- Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. Am J Clin Oncol 39(4):368-73, 2016. PMID: 24732810.
- Pugh TJ, Choi S, Nogueras-Gonzalez GM, Nguyen QN, Mahmood U, Frank SJ, Mathai B, Zhu R, Sahoo N, Gillin M, Kuban DA, Hoffman KE, McGuire SE, Lee AK. Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial. Int J Practice Ther, 2016. e-Pub 2016.
- Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 118(1):68-76, 2016. PMID: 26059275.
- Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy 15(3):274-82, 2016. e-Pub 2016. PMID: 26916105.
- Thaker NG, Sturdevant L, Jhingran A, Das P, Delclos ME, Gunn GB, McAleer MF, Tereffe W, Choi SL, Frank SJ, Simeone WJ, Martinez W, Hahn SM, Famiglietti R, Kuban DA. Assessing the Quality of a Radiation Oncology Case-Based, Peer-Review Program in an Integrated Academic and Community Cancer Center Network. J Oncol Pract 12(4):e476-86, 2016. e-Pub 2016. PMID: 26931402.
- Parker PA, Davis JW, Latini DM, Baum G, Wang X, Ward JF, Kuban D, Frank SJ, Lee AK, Logothetis CJ, Kim J. The Relationship Between Illness Uncertainty, Anxiety, Fear of Progression, and Quality of Life in Men With Favorable Risk Prostate Cancer Undergoing Active Surveillance. BJU Int 117(3):469-77, 2016. PMID: 25714186.
- Le CL, McFall SL, Byrd TL, Volk RJ, Cantor SB, Kuban DA, Mullen PD. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer. Narrat Inq Bioeth 6(1):51-61, 2016. PMID: 27346824.
- Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. Int J Radiat Oncol Biol Phys 93(2):294-302, 2015. e-Pub 2015. PMID: 26209502.
- Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, Hamstra DA, PROSTQA Study Consortium. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol 116(2):179-84, 2015. e-Pub 2015. PMID: 26276528.
- Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. BMC Cancer 15:190, 2015. e-Pub 2015. PMID: 25885406.
- Skolarus TA, Dunn RL, Sanda MG, Chang P, Greenfield TK, Litwin MS, Wei JT, PROSTQA Consortium, PROSTQA Consortium. Minimally important difference for the expanded prostate cancer index composite short form. Urology 85(1):101-6, 2015. PMID: 25530370.
- Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE. Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States. J Urol 192(6):1650-6, 2014. e-Pub 2014. PMID: 24931803.
- Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ. Establishing High-Quality Prostate Brachytherapy Using a Phantom Simulator Training Program. Int J Radiat Oncol Biol Phys 90(3):579-86, 2014. e-Pub 2014. PMID: 25151539.
- Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol 4(6):e239-46, 2014. e-Pub 2014. PMID: 25407875.
- Ballo MT, Chronowski GM, Schlembach PJ, Bloom ES, Arzu IY, Kuban DA. Prospective Peer Review Quality Assurance for Outpatient Radiation Therapy. Pract Radiat Oncol 4(5):279-84, 2014. e-Pub 2013. PMID: 25194094.
- Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study. JAMA Intern Med 174(9):1450-9, 2014. PMID: 25023650.
- Bilen MA, Hariri H, Leon C, Guo CC, Kuban DA, Pisters LL, Tu SM. Positive FDG-PET/CT Scans of a Residual Seminoma After Chemotherapy and Radiotherapy: Case Report and Review of the Literature. Clin Genitourin Cancer 12(4):147-50, 2014. e-Pub 2014. PMID: 24674785.
- Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw 12(7):993-8, 2014. PMID: 24994920.
- Volk RJ, McFall SL, Cantor SB, Byrd TL, Le YC, Kuban DA, Mullen PD. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer. Psychooncology 23(4):467-72, 2014. e-Pub 2013. PMID: 24243777.
- Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys 88(5):1074-84, 2014. PMID: 24661661.
- Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy 13(2):157-162, 2014. e-Pub 2013. PMID: 24050892.
- Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 2013. e-Pub 2013. PMID: 23798338.
- Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-9, 2013. e-Pub 2012. PMID: 22673704.
- Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?. Int J Radiat Oncol Biol Phys 85(3):693-9, 2013. PMID: 22836052.
- McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 2013. PMID: 23102837.
- Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol 189(1 Suppl):S2-S11, 2013. PMID: 23234625.
- Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ. Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer. Med Dosim 38(3):251-4, 2013. PMID: 23540491.
- Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M. Bladder cancer. J Natl Compr Canc Netw 11(4):446-75, 2013. PMID: 23584347.
- Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE. Outcomes in stage I testicular seminoma: A population-based study of 9193 patients. Cancer 119(15):2271-7, 2013. PMID: 23633409.
- Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 86(5):835-41, 2013. PMID: 23726001.
- Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, Wei JT, Sanda MG, Michalski JM, PROSTQA Consortium Study Group. Multi-institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated With Patient-Reported Outcomes: The PROSTQA Experience. Int J Radiat Oncol Biol Phys 86(3):546-53, 2013. PMID: 23561651.
- Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis 16(4):346-51, 2013. e-Pub 2013. PMID: 23939133.
- Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M. Penile Cancer: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 11(5):594-615, 2013. PMID: 23667209.
- Corn PG, Song DY, Heath E, Maier J, Meyn R, Kuban D, DePetrillo TA, Matthew P. Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer. Results from a Multi-Institutional Phase I Study. Int J Radiat Oncol Biol Phys 86(3):540-5, 2013.
- Kazer MW, Bailey DE Jr, Chipman J, Psutka SP, Hardy J, Hembroff L, Regan M, Dunn RL, Crociani C, Sanda MG, [Kuban DA]. PROST QA Consortium Study Group. BJU Int 111(3 pt B):E84-91, 2013.
- Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 87(5):946-53, 2013. e-Pub 2013. PMID: 24139077.
- Gay HA, Michalski JM, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, Kuban D, Hembroff L, Chang P, Sanda MG, PROSTQA Consortium. Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology 82(6):1363-9, 2013. e-Pub 2013. PMID: 24139340.
- Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker SL, Kuban D, Dong L. Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer. Pract Radiat Oncol 3(4):329-36, 2013. PMID: 24674406.
- Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 9(9):2346-52, 2012. e-Pub 2012. PMID: 22357249.
- Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen QN, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-4, 2012. PMID: 21875820.
- Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 18(1):1-8, 2012. PMID: 22290249.
- Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?. Eur J Cancer 48(11):1664-71, 2012. PMID: 22336663.
- Boonsirikamchai P, Kaur H, Kuban DA, Jackson E, Hou P, Choi H. Use of maximum slope images generated from dynamic contrast-enhanced MRI to detect locally recurrent prostate carcinoma after prostatectomy: a practical approach. AJR Am J Roentgenol 198(3):W228-36, 2012. PMID: 22358019.
- Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X. A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys 83(4):1169-78, 2012. PMID: 22704703.
- Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening Colonoscopy Before Prostate Cancer Treatment Can Detect Colorectal Cancers in Asymptomatic Patients and Reduce the Rate of Complications After Brachytherapy. PRO 2(3):e7, 2012.
- Brooks C, Sheu T, Bridges K, Mason K, Kuban D, Mathew P, Meyn R. Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer. Radiat Oncol 7(1):154, 2012. PMID: 22967802.
- Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Yeh SF, Frank SJ. Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate. Brachytherapy 11(6):429-34, 2012. e-Pub 2012. PMID: 22727472.
- Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A. Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?. Int J Radiat Oncol Biol Phys 79(5):1310-7, 2011. e-Pub 2010. PMID: 20493642.
- Iyengar P, Levy LB, Choi S, Lee AK, Kuban DA. Toxicity Associated With Postoperative Radiation Therapy for Prostate Cancer. Am J Clin Oncol 34(6):611-8, 2011. PMID: 21150565.
- Hoffman KE, Nguyen PL, Chen MH, Chen RC, Choueiri TK, Hu JC, Kuban DA, D'Amico AV. Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol 185(1):116-20, 2011. e-Pub 2010. PMID: 21074194.
- Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA 306(11):1205-14, 2011. PMID: 21934053.
- Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ. Long-term tumor control after brachytherapy for base-of-prostate cancer. J Contemp Brachytherapy 3(4):183-7, 2011. e-Pub 2011. PMID: 23346126.
- Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles During a Course of Intensity-Modulated Radiation Therapy. Am J Clin Oncol 33(2):173-5, 2010. PMID: 20010077.
- Archambault L, Briere TM, Pönisch F, Beaulieu L, Kuban DA, Lee A, Beddar S. Toward a Real-Time In Vivo Dosimetry System Using Plastic Scintillation Detectors. Int J Radiat Oncol Biol Phys 78(1):280-7, 2010. e-Pub 2010.
- Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol 96(1):6-12, 2010. e-Pub 2010. PMID: 20400191.
- Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model. Int J Radiat Oncol Biol Phys 78(4):1253-60, 2010.
- Lawton C, Michalski J, El-Naqa I, Kuban D, Lee W, Rosenthal S, Zietman A, Sandler H, Shipley W, Ritter M, Valicenti R, Cattan C, Roach M, Pisansky T, Seider M.. Variation in the Definition of Clinical Target Volumes for Pelvic Nodal Conformal Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 74(2):377-82, 2009. PMID: 18947941.
- Montie JE, Clark PE, Eisenberger MA, El-Galley R, Greenberg RE, Herr HW, Hudes GR, Kuban DA, Kuzel TM, Lange PH, Lele SM, Michalski J, Patterson A, Pohar KS, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG, Wilson TG. Bladder cancer. J Natl Compr Canc Netw 7(1):8-39, 2009. PMID: 19176203.
- Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, Vulpen MV, Swanson DA. Prostogram Predicted Brachytherapy Outcomes are Not Universally Accurate: An Analysis Based on the M. D. Anderson Cancer Center Experience With (125)Iodine Brachytherapy. J Urol 181(4):1658-63, 2009. PMID: 19233434.
- Tu SM, Lopez A, Leibovici D, Bilen M, Evliyaoglu F, General RD, Aparicio A, Pagliaro LC, Guo CC, Kuban DA, Johnson MM, Logothetis CJ, Lin SH, Pisters LL. Ductal Adenocarcinoma of the Prostate - Clinical Features and Implications After Local Therapy. Cancer 115(13):2872-80, 2009. PMID: 19402048.
- Williams BJ, Fox BD, Sciubba DM, Suki D, Tu SM, Kuban D, Gokaslan ZL, Rhines LD, Rao G. Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine 10(5):414-22, 2009. PMID: 19442002.
- Madsen LT, Craig C, Kuban D. A multidisciplinary prostate cancer clinic for newly diagnosed patients: developing the role of the advanced practice nurse. Clin J Oncol Nurs 13(3):305-9, 2009. PMID: 19502188.
- Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience. Oncology 77(2):75-81, 2009. PMID: 19571599.
- Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience. Urology 74(3):601-5, 2009. PMID: 19589580.
- Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol 182(5):2232-41, 2009. e-Pub 2009. PMID: 19781717.
- Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70(1):67-74, 2008. PMID: 17765406.
- O'Daniel, Dong L, Zhang J, Wang C, Tucker S, Kudchadker R, Lee AK, Cheung MR, Cox J, Kuban D, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-280, 2008.
- Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era?. Int J Radiat Oncol Biol Phys 72(2):623-7, 2008. PMID: 18410998.
- Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Muchalski JM, Zefelsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin L, Deweese TL. Scardino PT, Stephenson AJ, Pollack A.. A Multi-Institutional Matched-Control Analysis of Adjuvant and Salvage Postoperative Radiation Therapy for pT3-4N0 Prostate Cancer. Urology 72(6):1298-302, 2008. PMID: 18672274.
- Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250-61, 2008. PMID: 18354103.
- Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 2008. PMID: 18207664.
- Wang H, Garden AS, Zhang L, Wei X, Ahamad A, Kuban DA, Komaki R, O'Daniel J, Zhang Y, Mohan R, Dong L. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 72(1):210-9, 2008. PMID: 18722272.
- Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M, Clarke DH, Stock RG, Robert Lee W, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States. Brachytherapy 6(1):2-8, 2007. PMID: 17284379.
- Vance W, Tucker SL, de Crevoisier R, Kuban DA, Cheung MR. The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. Int J Radiat Oncol Biol Phys 67(3):828-33, 2007. PMID: 17161554.
- Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67:327-33, 2007. PMID: 17084558.
- Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys 67(2):620-9, 2007. PMID: 17236979.
- Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67(4):1059-65, 2007. PMID: 17241755.
- Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high-dose external beam radiation therapy, and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177(6):2151-6, 2007. PMID: 17509305.
- Kry SF, Followill D, White RA, Stovall M, Kuban DA, Salehpour M. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1265-71, 2007. PMID: 17637398.
- de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L. Changes in the Pelvic Anatomy After an IMRT Treatment Fraction of Prostate Cancer. Int J Radiat Oncol Biol Phys 68(5):1529-36, 2007. PMID: 17544595.
- Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, Deweese TL, Sandler HM. Predictive Factors for late Genitourinary and Gastrointestinal Toxicity in Patients With Prostate Cancer Treated With Adjuvant or Salvage Radiotherapy. Int J Radiat Oncol Biol Phys 68(5):1417-23, 2007. e-Pub 2007. PMID: 17418972.
- Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol 85(2):251-259, 2007. PMID: 17892900.
- Vassiliev ON, Kry SF, Kuban DA, Salehpour M, Mohan R, Titt U. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys 68(5):1567-71, 2007. PMID: 17544596.
- Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. Am J Clin Oncol 25(15):2035-41, 2007. PMID: 17513807.
Invited Articles
- Bellmunt J, Attard G, Bahl A, Huland H, Klotz L, Kuban D, Oudard S, Watson W. Advances in the management of high-risk localized and metastatic prostate cancer. BJU Int 109(Suppl 2):8-13, 2012. PMID: 22257099.
- Carducci MA, Montie JE, Kuban DA.. Perspectives on the Management of Localized Prostate Cancer. American Society of Clinical Oncology, Educational Book, 2009.
- Kuban DA, Dong L, Cheung R, Strom E, De Crevoisier R. Ultrasound-based localization. Semin Radiat Oncol 15:180-91, 2005. PMID: 15983943.
- Kuban DA, Dong L. High-dose intensity modulated radiation therapy for prostate cancer. Curr Urol Rep 5:197-202, 2004. PMID: 15161568.
- Kuban DA, Thames HD, Levy LB. PSA after radiation for prostate cancer. Oncology (Williston Park) 18:595-604; discussion 605, 609, 2004. PMID: 15209188.
- Kuban DA, Thames HD, Levy LB. Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy. World J Urol 21:253-64, 2003. PMID: 12923658.
- Logothethis CJ, Kattan MW, Keane TE, Kuban DA. The foundation for optimal integrated therapy in the management of prostate cancer-CME Home Study, Quintiles Medical Communications, Hawthorne, NY. Quintiles Medical Communications, Hawthorne, NY, 2002.
- Kattan MW, Keane TE, Kuban DA, Logothetis CJ, Pienta KJ, Sandler HM, Scher HI. The foundation for optimal integrated therapy in the management of prostate cancer- CME Teleconference Series, Quintiles Medical Communications, Hawthorne, NY. Quintiles Medical Communications, Hawthorne, NY, 2002.
- Kuban DA, Partin, et al. Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer. Oncology 16(8):1042, 2002.
Manuals, Teaching Aids, Other Teaching Publications
- Volk R, Pettaway C, Kuban D. Knowing Your Options: A Decision Aid for Men with Clinically Localized Prostate Cancer. A Patient Decision Aid Released by AHRQ, 2011.
- Kuban DA,. Multidisciplinary Prostate Cancer Clinic. A Guide to Treatment Options, 2008.
- Kuban DA. Genitourinary Radiation Guide. U. T. M. D. Anderson Cancer Center, Dept of Radiation Oncology, 2003.
Other Articles
- Kuban DA Book Review of Image-Guided Radiation Therapy of Prostate Cancer. Int J Rad Oncol Biol Phys, 2008.
Editorials
- Hoffman KE, Kuban DA. Lymph node-positive prostate cancer: the benefit of local therapy. Oncology (Williston Park) 27(7):655, 660-1, 2013. PMID: 23977760.
- Kuban DA, Pagliaro L. Salvage Radiotherapy or Observation After Radical Prostatectomy in the PSA era. The American Journal of Hematology/Oncology 8(3):136-138, 2009.
- Kuban DA. Localized prostate cancer: the battle of treatment options enters the larger arena. Oncology (Williston Park) 23(10):867, 873, 2009. PMID: 19839428.
- Kuban DA. Reconsidering the case for brachytherapy plus EBRT in high-risk prostate cancer. Oncology 22:1006-1012, 2008.
- Kuban Deborah A. Does Postoperative Adjuvant Radiotherapy Reduce Biochemical Progression after Radical Prostatectomy?. Nat Clin Pract Urol 3(2):70-1, 2006. PMID: 16470200.
- Kuban DA. Permanent prostate brachytherapy: Is supplemental external-beam radiation therapy necessary?. Oncology 20:522-523, 2006.
- Kuban DA. Prostate-Specific Antigen as a Marker of Disease Activity in Prostate Cancer. Oncology 16:1042, 2002.
- Kuban DA Roche et al. Comment on "Spectroscopy in prostate cancer: Hope or hype"?. Oncology 15:1415, 2001.
Abstracts
- Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int 121(1):69-76, 2018. e-Pub 2017. PMID: 28710901.
- Choi S, Levy LB, Lee KK, Nguyen QN, Lee AK, McGuire SE, Kudchadker R, Du W.. Identifying a Subgroup of High-Risk Prostate Cancer Patients with Worse Clinical Outcomes: Should there Be a "Very High-Risk" Group?. Int J Radiat Oncol Biol Phys 96(2):E240-E241, 2016.
- Hoffman KE, Voong KR, Levy LB, Pugh TJ, Choi S, Du W, Frank SJ, Johnson JL, Kudchadker R, Nguyen QN, Lee AK, Mahmood U, McGuire SE, Kuban DA,. Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 96(2):S32, 2016.
- Frank SJ, Pugh TJ, Mahmood U, Blanchard P, Kudchadker R, Graber W, Kuban DA, Choi S.. The Value of Brachytherapy for Intermediate-Risk Localized Prostate Cancer Using Ichom Outcomes and Time-Driven Activity-Based Costing: Results From a Phase 2 Prospective Trial of 300 Patients. Int J Radiat Oncol Biol Phys 96(2):E400-E401, 2016.
- Blanchard P, Davis JW, Frank SJ, Jeri K, Pettaway CA, Pugh TJ, Pisters LL, Mahmood U.. How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort. Int J Radiat Oncol Biol Phys 96(2):E534-E535, 2016.
- Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Achim MF, Wang X, Choi S, Kuban DA, Troncoso P, Logotheitis C, Thompson TC, Kim J.. Plasma caveolin-1 to predict disease reclassification in men with early stage prostate cancer in active surveillance. J Clin Oncol 34, 2016.
Book Chapters
- Walker G, Kuban DA. Prostate Intact. In: Pocket Guide to Radiation Oncology. Springer: New York, NY, 155-158, 2017.
- Kumar R, Kuban DA. Adjuvant/Salvage Prostate Cancer. In: Pocket Guide to Radiation Oncology. Springer: New York, NY, 159-162, 2017.
- Kumar R, Kuban DA. Bladder Cancer. In: Pocket Guide to Radiation Oncology. Springer: New York, NY, 163-166, 2017.
- Walker G, Kuban DA. Seminoma. In: Pocket Guide to Radiation Oncology. Springer: New York, NY, 167-170, 2017.
- Patterson ML, Davis JW, Kim J, Hoffman KE, Osai WE, Kuban DA. Genitourinary Cancer Survivorship Management. In: Advances in Cancer Survivorship Management. Springer: New York, NY, 95-104, 2014.
- Kundra V, Martin S, Kuban D. Prostate Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier - Saunders: Philadelphia, PA, 377 - 402, 2012.
- Michalski J, Potters L, Lawton CA, Pisansky TM, Kuban DA.. Prostate Cancer. In: Clinical Radiation Oncology. Third Edition. Churchill Livingston, an imprint of Elsevier, Inc: Philadelphia, PA, 1037 - 1097, 2011.
- Kuban DA, Trad ML, Contributors. In: Radiation Therapy Study Guide and Exam Review. Mosby, Inc: St. Louis, MO, 2011.
- Logothetis CJ, Troncoso P, Kim J, Davis JW, Kuban DA, Mathew P, Aparicio A.. Neoplasms of the Prostate. In: Cancer Medicine 8th Edition. PMPH-USA: Shelton, CT, 1228 - 1254, 2010.
- Kuban DA, Cheung R, Meistrich ML, Hussey DH. The Testicle. In: Radiation Oncology: Rationale, Technique, Results. Mosby, Inc: St. Louis, MO, 653 - 675, 2009.
- Kuban DA, Trad ML.. Male Reproductive and Genitourinary Tumors. In: Principles and Practice of Radiation Therapy. Mosby, Inc: St. Louis, MO, 823 - 865, 2009.
- Kuban DA, Potters L, Lawton CA, Pisansky TM. Prostate Cancer. In: Clinical Radiation Oncology. Churchill Livingston an imprint of Elsevier, Inc: Philadelphia, PA, 1165 - 1236, 2007.
- Thompson I, Kuban DA, Blasko J . How do they test for prostate cancer?. In: The Prostate Cancer Treatment Book. McGraw Hill: New York, NY, 37, 2003.
- Friedland J, Kuban DA, Lee WR, Sylvester J, Friedland J. What happens after the implant?. In: The Prostate Cancer Treatment Book. McGraw Hill: New York, NY, 139, 2003.
- Kuban DA. Male reproductive and genitourinary tumors. In: Principles and Practice of Radiation Therapy: Practical Applications. Mosby-Year Book, Inc, 244-289, 2002.
- El-Mahdi AM Kuban DA. Radiation damage of the female and male genitalia. In: Reconstructive surgery of the external genitalia, 2000.
- Kuban DA, El-Mahdi AM, Schellhammer PF. Radiation therapy for Stage T1 and T2 prostate cancer. In: A Comprehensive Textbook of Genitourinary Oncology. Williams & Wilkins, 739-754, 2000.
- Kuban DA, Hunt DE, El-Mahdi AM. Cancers of the genitourinary tract. In: Treatment Planning in Radiation Oncology. Williams & Wilkins, 369-404, 1997.
- Schellhammer PF, Kuban DA, El-Mahdi AM . Overview of options for localized prostate cancer. In: Principles and Practice of Genitourinary Oncology. Lippincott-Raven, 573-582, 1997.
- Kuban DA, El-Mahdi AM, Schellhammer PF. Radiation therapy for Stage T1 and T2 prostate cancer. In: A Comprehensive Textbook of Genitourinary Oncology. Williams & Wilkins, 759-781, 1995.
- El-Mahdi AM Kuban DA . Cord compression. In: Practical Approaches to Cancer Invasion and Metastases. Springer-Verlag , 46-48, 1994.
- Kuban DA El-Mahdi AM. Radiotherapy versus radical prostatectomy: Two options in the treatment of localized prostate carcinoma. In: Controversies in the management of prostate cancer, a six-part clinical monograph series. CoMed Communications, Part 3, pages 4-11, 1990.
Grant & Contract Support
| Title: | Kuban DA |
| Funding Source: | U. T. M. D. Anderson Start-up Research Funds |
| Role: | Principal Investigator |
| Title: | Image-Guided Prostate Cancer Radiotherapy |
| Funding Source: | Prostate Cancer Research Program |
| Role: | Co-Investigator |
| Title: | A Sexual Counseling Intervention for Prostate Cancer Survivors |
| Funding Source: | ACS |
| Role: | Co-Investigator |
| Title: | Epidemiologic Molecular and Clinical Markers of Prostate Cancer Progression |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | The Relationship of Obesity, Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 To Outcome After Radiation for Prostate Cancer |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator |
| Title: | Long-term Multi-Institutional Analysis of Treatment for Prostate Cancer |
| Funding Source: | Amersham Health Care |
| Role: | Principal Investigator |
| Title: | Radiological Physics Center |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Dose Volume Modeling of Late Rectal and Bladder Toxicity |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Online Image-guided IMRT for Inter-Fractional Changes |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Survivor QOL and Spouse Satisfaction after Prostate Therapy |
| Funding Source: | NIH/NCI |
| Role: | Co-Principal Investigator |
| Title: | A Comprehensive, Multimodality Quality of Life Study for Prostate Cancer |
| Funding Source: | UTMDACC Prostate Cancer Research Program |
| Role: | Principal Investigator |
| Title: | Real-time in vivo Dosimetry in Radiation Therapy using Scintillation Detectors |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Efficacy of Cancer Support Group Programs: A Social Comparison Theory Analysis |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Optimizing the Delivery of Lifestyle Interventions in Cancer Survivors |
| Funding Source: | U.T.M.D. Anderson Multidisciplinary Research Program |
| Role: | Co-Investigator |
| Title: | U10 Full Member Application Affiliated with SWOG |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Evaluating the role of genetic makers in prostate cancer progression |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-Investigator |
| Title: | Molecular Epidemiology of t-MDS/AML |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | A Sexual Counseling Intervention for Prostate Cancer Survivirs |
| Funding Source: | OPFR |
| Role: | Co-Investigator |
| Title: | Acceptability of Active Surveillance as a Treatment Choice for Prostate Cancer among U.S. Men |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
| Title: | Comparative Effectiveness of Treatments for Localized Prostate Cancer |
| Funding Source: | Recovery Act 2009 AHRQ Choice Grant |
| Role: | Co-Investigator |
| Title: | Understanding how to implement and measure shared decision-making |
| Funding Source: | National Committee on Quality Assurance |
| Role: | Co-Investigator |
| Title: | R-Clinical Decisions and Communication Sciences (The John M. Eisenberg Center for Clinical Decisions and Communications Science) |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Consultant/Medical Content Expert |
Patient Reviews
CV information above last modified August 16, 2024